New Inflammatory Marker Associated with Disease Activity in Gouty Arthritis: The Systemic Inflammatory Response Index by Jiang Y, Tu X, Liao X, He Y, Wang S, Zhang Q, Qing Y

Connect to this object online.

Expression Profile of Pyroptosis-Related Genes and the Associated Regulatory Axis in Primary Gout Patients by Niu S, Lei TY, Dai F, Xie H, Yu X, Zhang Q, Qing Y

Connect to this object online.

Analysis of the Potential Link Between Dermatomyositis and Cancer by Guo J, Lei T, Yu X, Wang P, Xie H, Jian G, Zhang Q, Qing Y

Connect to this object online.

Investigation and Confirmation of PYCARD as a Potential Biomarker for the Management of Psoriasis Disease by Xu B, Yu B, Xu Z, Ye S, Qing Y, Sun H, Zhao B, Wu N, Wu J

Connect to this object online.

Upregulation of PD-L1 and APE1 is associated with tumorigenesis and poor prognosis of gastric cancer by Qing Y, Li Q, Ren T, Xia W, Peng Y, Liu GL, Luo H, Yang YX, Dai XY, Zhou SF, Wang D

Connect to this object online.

Harnessing the Systemic Immunoinflammatory Index as a Potential Predictive Tool for Recurrent or Metastatic Nasopharyngeal Carcinoma Undergoing PD-L1 Inhibitor by Song G, Wei Z, Pei Y, Liu Z, Min Y, Li H, Gao K, Ge J, Qing Y, Wei Y, Chen Y, Peng X

Connect to this object online.

Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated... by Ren T, Shan J, Qing Y, Qian C, Li Q, Lu G, Li M, Li C, Peng Y, Luo H, Zhang S, Zhang W, Wang D, Zhou SF

Connect to this object online.

Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell l... by Ren T, Shan J, Li M, Qing Y, Qian C, Wang G, Li Q, Lu G, Li C, Peng Y, Luo H, Zhang S, Yang Y, Cheng Y, Wang D, Zhou SF

Connect to this object online.